On Demand Therapeutic Plasma Exchange
The advent of an aging population worldwide has increased dementia incidence, a significant public health issue.
How Does Therapeutic Plasma Exchange Help Alzheimer’s Disease and Live Longer?
While currently TPE is recommended as a treatment option for those with behavioral problems and/or mild cases of Alzheimer's, studies have shown that this treatment could also play a role in treating patients who have severe memory loss problems or who are facing other memory impairments. This treatment has been shown to reduce levels of amyloid beta and other harmful proteins while also reducing overall inflammation in the brain.
Researchers from the AMBAR (Alzheimer's Management by Albumin Replacement) study found that the transplant of blood plasma containing albumin protein improved memory, language, and quality of life in patients suffering from mild-to-moderate Alzheimer's disease.
Alzheimer's disease (AD) is the most common form of dementia. It is a progressive, irreversible, and terminal neurodegenerative disorder. A person with Alzheimer's may be disoriented about time and place or have trouble communicating or problem-solving.
According to Mayo Clinic, Alzheimer's disease can be divided into three stages: preclinical, mild cognitive impairment (MCI), and severe dementia due to AD. The preclinical stage occurs when the patient does not show any symptoms but has undergone significant changes in brain structure andfunction. The MCI stage is characterized by subtle cognitive changes but no functional impairment; these patients are often able to continue their work despite the changes in cognition. In the final stage, patients are unable to perform their daily activities independently because they cannot remember how to do them or recall how they were done before having dementia.
Alzheimer's disease (AD) is the most common form of dementia. It is a progressive, irreversible, and terminal neurodegenerative disorder. A person with Alzheimer's may be disoriented about time and place or have trouble communicating or problem-solving.
According to Mayo Clinic, Alzheimer's disease can be divided into three stages: preclinical, mild cognitive impairment (MCI), and severe dementia due to AD. The preclinical stage occurs when the patient does not show any symptoms but has undergone significant changes in brain structure andfunction. The MCI stage is characterized by subtle cognitive changes but no functional impairment; these patients are often able to continue their work despite the changes in cognition. In the final stage, patients are unable to perform their daily activities independently because they cannot remember how to do them or recall how they were done before having dementia.
